SEC Filing Summary: Harvard Bioscience Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on March 2, 2004. The filing serves to announce the company's financial results for the quarter and fiscal year ended December 31, 2003. The report incorporates by reference a press release issued on the same date (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) which is referenced but not reproduced in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It solely acts as a notification that results for the period ended December 31, 2003, have been released.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. Such information, if present, is located in the referenced press release.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue and net income figures for Q4 and FY 2003.
- Verify year-over-year growth rates and margin trends not detailed in this summary.
- Check for any updated financial guidance or strategic shifts mentioned in the full press release.
- Confirm the company's liquidity position and debt obligations as of December 31, 2003.